BMA Stock Analysis: Buy, Sell, or Hold?

BMA - Banco Macro S.A.

Commercial Banks, NEC
$77.37
7.32 (10.45%) ▲
5d: +9.76%
30d: +0.79%
90d: -14.35%
BUY
HIGH Confidence
Analysis Updated: Mar 31, 2026 12:00 AM ET
Earnings: Feb 25, 2026 0d

Get Alerted When BMA Hits Your Target Price

Join 10,000+ traders who never miss a move

You're in! Check your email to confirm and set your target price.
100% Free No spam, ever Unsubscribe anytime

Interactive Price Chart (1 Month)

Loading chart...

Loading historical data...

💡
Bottom Line:
✅ BUY SIGNAL: BMA shows strong fundamentals and good volume confirmation. Solid entry point despite slightly high pricing.

Long-Term Wealth Forecast (2031)

Based on Analyst Consensus Growth & Historical Valuation

0% (Stagnation) 50% (Hyper Growth)
EST. PRICE IN 2031
$562551.00
Based on 14.5% avg growth
INTRINSIC VALUE TODAY
$349299.91
100.0% Margin of Safety

How this is calculated: We use a Growth Decay Model: starting with analyst consensus growth (adjusted above) and gradually slowing it down to a long-term terminal rate (4%) by Year 5. This provides a more realistic valuation than assuming constant hyper-growth. We then apply a 20.0x Exit PE.

In-depth Analysis How we analyze

Valuation Analysis: BMA is currently trading at $77.37, which is considered slightly high relative to its 30-day fair value range of $66.99 to $80.30. At these levels, the market is pricing in 16.4% annual earnings growth.

Technical Outlook: Technically, BMA is in a downtrend. The price is approaching resistance at $75.03. A breakout above this level would be a bullish signal, while rejection here could lead to consolidation. The stock is showing strong short-term momentum, up 10.4% recently.

Market Sentiment: BMA has a strong technical setup (60/100), with favorable trendlines, momentum, and price action for short-term traders. In the options market, Implied Volatility is low (17th percentile), suggesting options premiums are relatively cheap. This makes it an attractive time for long options strategies if you have a directional bias. Wall Street analysts see significant upside, with an average price target of $116.25 (+50.3%). Combining these factors, the current setup offers a favorable risk/reward ratio for buyers.

Quick Decision Summary

Current Position SLIGHTLY HIGH
Fair Price Range $66.99 - $80.30
Company Quality Score 59/100 (HOLD)
Options IV Signal 17th percentile (COMPLACENCY WARNING)
Volume Confirmation HIGH
Confidence Score 87.3%

All Signals

  • BULLISH: Options cheap (IV 17th percentile)
  • BULLISH: Strong technical setup (60/100)
  • BULLISH: High volume confirmation
  • BULLISH: Strong upward momentum (+10.4%)
  • BULLISH: Trading 50.3% below Wall St target ($116.25)
  • BULLISH: Expecting earnings turnaround to 16.4% growth with 7.6% revenue growth

Fair Price Analysis

30-Day Fair Range $66.99 - $80.30
Current vs Fair Value SLIGHTLY HIGH
Expected Move (7 Days) ±$6.56 (8.5%)

Support & Resistance Levels

Support Level $65.00
Resistance Level $75.03
Current Trend Downtrend
Technical data as of Mar 31, 2026

Fundamental Context

Forward P/E (Next Year Est.) 0.01
Wall Street Target $116.25 (+50.3%)
Revenue Growth (YoY) 7.6%
Earnings Growth (YoY) -22.3%
Profit Margin 7.1%
Valuation Premium vs History +16.4% premium
Market-Implied Price Targets If current PE multiple persists
Implied Growth (YoY): +16.4% (market-implied from PE analysis)
1-Year Target $90.06 (+16%)
2-Year Target $104.83 (+36%)
3-Year Target $122.02 (+58%)
3-Year Scenarios Using analyst projected EPS growth
Bull: (PE: 22.4, Growth: 51.5%) $1089525.51 (+1408102%)
Base: (SPY PE: 0.0, Growth: 51.5%) $261.12 (+238%)
Bear: (PE: 0.0, Growth: 51.5%) $221.96 (+187%)
📈 Valuation based on Current Earnings
RECOVERY PLAY: Stock looks expensive now (26x PE), but valuation improves significantly next year (0x PE) as earnings recover.
Trailing PE: 26.24 | Current EPS (TTM): $2.58
Bull Case $148.92 (+112%)
Analyst growth 100.0%, PE expands to 28.9
Base Case $135.38 (+93%)
Market implied 100.0%, PE stable at 26.2
Bear Case $46.03 (-35%)
Severe decline -20.0%, PE contracts to 22.3
These are projections based on PE multiples and EPS growth scenarios, not predictions. Actual results may vary significantly.
Share & Embed Analysis

Found this analysis useful? Share it with your community or embed the live chart on your blog.

Tweet Reddit
bloggers & journalists: you are free to use our charts with attribution.
Last updated: April 01, 2026 2:31 AM ET
Data refreshes hourly during market hours. Next update: 3:31 AM
🔥 Top Stocks Breaking Out Now
Ticker Score Recommendation Change %
Technical Signals Check
Insider Activity (6 Months)
0
Buys
0
Sells
0
Net
NEUTRAL

Unlock Insider Activity

See real-time buying/selling by company executives for BMA.

Create Free Account

Already have an account? Log In

Top Rated Banks - Regional Stocks

Top-rated stocks in Banks - Regional by analyst ratings.

Stock Analyst Consensus Analyst Target Tradestie Score
USB
U.S. Bancorp
BUY
24 analysts
$64 63 BUY
PNC
PNC Financial Services G…
BUY
23 analysts
$251 61 BUY
WBS
Webster Financial Corpor…
STRONG BUY
16 analysts
$75 57 HOLD
WAL
Western Alliance Bancorp…
STRONG BUY
15 analysts
$97 60 BUY
MTB
M&T Bank Corporation
BUY
21 analysts
$235 60 HOLD

More Analysis for BMA

BMA Technical Chart BMA Price Prediction BMA Earnings Date BMA Investment Advisor BMA Fair Price Analyzer BMA Competitors
Live Trades
From trading groups
Loading trades...
View All Live Trades See Trader Consensus & Signals